Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2008 1
2009 1
2010 1
2011 1
2012 2
2013 3
2014 2
2015 1
2016 1
2017 1
2018 1
2019 3
2020 4
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 3 Hemorrhoids, CTCAE"
Page 1
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S, Jensen NBK, Pötter R, Fokdal LU, Chargari C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Hoskin P, Segedin B, Rai B, Bruheim K, Wiebe E, Van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Lutgens LCHW, Tan LT, Villafranca E, Smet S, Jastaniyah N, Nout RA, Kirisits C, Chopra S, Kirchheiner K, Tanderup K, Embrace Collaborative Group. Spampinato S, et al. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):681-693. doi: 10.1016/j.ijrobp.2021.09.055. Epub 2021 Oct 20. Int J Radiat Oncol Biol Phys. 2022. PMID: 34678431
CTCAE severe grade (grade [G] 3) events were pooled according to the location in the GI tract (anus/rectum, sigmoid, and colon/small bowel). ...Logistic regression was used for persistent G 1 and EORTC "quite a bit" symptoms, defined if present …
CTCAE severe grade (grade [G] 3) events were pooled according to the location in the GI tract (anus/rectum …
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N. Meixner E, et al. Radiat Oncol. 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. Radiat Oncol. 2023. PMID: 36624483 Free PMC article. Clinical Trial.
Symptoms were assessed using Common Terminology Criteria for Adverse Events (CTCAE) and institutional patient-reported symptoms grading. RESULTS: Scores regarding global health status were markedly impaired at baseline (mean: 58.0 20.1) compared to reference …
Symptoms were assessed using Common Terminology Criteria for Adverse Events (CTCAE) and institutional patient-reported symptoms gr …
Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer.
Takakusagi Y, Katoh H, Kano K, Anno W, Tsuchida K, Mizoguchi N, Serizawa I, Yoshida D, Kamada T. Takakusagi Y, et al. Radiat Oncol. 2020 May 27;15(1):127. doi: 10.1186/s13014-020-01575-7. Radiat Oncol. 2020. PMID: 32460889 Free PMC article.
The biochemical relapse-free rate in the low-, intermediate-, and high-risk groups at 3 years was 87.5, 88.0, and 97.5%, respectively (P = 0.036). Grade 2 acute urinary toxicity was observed in 12 (4.7%) patients. Grade 2 acute rectal toxicity was not …
The biochemical relapse-free rate in the low-, intermediate-, and high-risk groups at 3 years was 87.5, 88.0, and 97.5%, respectively …
Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A, Agolli L, Baumann M, Troost EGC, Krause M, Hölscher T, Löck S. Dutz A, et al. Acta Oncol. 2019 Jun;58(6):916-925. doi: 10.1080/0284186X.2019.1581373. Epub 2019 Mar 18. Acta Oncol. 2019. PMID: 30882264
The majority of patients in both groups reported high functioning and low symptom scores for the QoL questionnaires before and after RT. No or little changes were observed for most items between baseline and 3 or 12 months after RT, respectively. Global healt …
The majority of patients in both groups reported high functioning and low symptom scores for the QoL questionnaires before and after …
Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature.
Fakhrian K, Sauer T, Dinkel A, Klemm S, Schuster T, Molls M, Geinitz H. Fakhrian K, et al. Strahlenther Onkol. 2013 Jun;189(6):486-94. doi: 10.1007/s00066-013-0314-5. Epub 2013 May 2. Strahlenther Onkol. 2013. PMID: 23636349 Review.
Both FACT-C and CAE information were available for 42 patients, allowing evaluation of the impact of CAE on QOL. The median total FACT-C score was 110 (40-132) out of a possible maximum of 136. The absence of grade 3 CAE (115 vs. 94, p = 0.001); an interval o …
Both FACT-C and CAE information were available for 42 patients, allowing evaluation of the impact of CAE on QOL. The median total FACT-C …
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study.
Chapet O, Udrescu C, Bin S, Decullier E, Fenoglietto P, Beneux A, Segui B, Enachescu C, Gaudioz S, Ruffion A, Azria D. Chapet O, et al. Br J Radiol. 2021 Aug 1;94(1124):20210242. doi: 10.1259/bjr.20210242. Br J Radiol. 2021. PMID: 34282946 Free PMC article. Clinical Trial.
A transperineal injection of 10cc of HA was performed between the rectum and the prostate. Late toxicities were evaluated between 3 and 36 months after the end of treatment (CTCAE v4). ...CONCLUSION: Despite the inefficacy of HA injection was not rejected, we …
A transperineal injection of 10cc of HA was performed between the rectum and the prostate. Late toxicities were evaluated between …
High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events.
Romano KD, Hill C, Trifiletti DM, Peach MS, Horton BJ, Shah N, Campbell D, Libby B, Showalter TN. Romano KD, et al. Radiat Oncol. 2018 Jul 16;13(1):129. doi: 10.1186/s13014-018-1074-2. Radiat Oncol. 2018. PMID: 30012164 Free PMC article.
Statistical analyses were used to investigate clinical and dosimetric predictors of GI and GU toxicity following HDR brachytherapy according to CTCAE v4.0 grading criteria. RESULTS: Fifty-six women with FIGO IB1 - IVA cervical cancer were included. The overal …
Statistical analyses were used to investigate clinical and dosimetric predictors of GI and GU toxicity following HDR brachytherapy ac …
Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study.
Tharmalingam H, Tsang Y, Ostler P, Wylie J, Bahl A, Lydon A, Ahmed I, Elwell C, Nikapota AR, Hoskin PJ; National UK HDR Prostate Brachytherapy Database. Tharmalingam H, et al. Radiother Oncol. 2020 Feb;143:95-100. doi: 10.1016/j.radonc.2019.12.017. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044166
PATIENTS AND METHODS: Seven centres across the UK collaborated in this national protocol to deliver 19 Gy to the PTV defined by the prostate capsule and a 3 mm expansion with clearly defined planning constraints for the urethra and rectum. ...Acute toxicity was low …
PATIENTS AND METHODS: Seven centres across the UK collaborated in this national protocol to deliver 19 Gy to the PTV defined by the prostate …
Proctitis following stereotactic body radiation therapy for prostate cancer.
Joh DY, Chen LN, Porter G, Bhagat A, Sood S, Kim JS, Moures R, Yung T, Lei S, Collins BT, Ju AW, Suy S, Carroll J, Lynch JH, Dritschilo A, Collins SP. Joh DY, et al. Radiat Oncol. 2014 Dec 12;9:277. doi: 10.1186/s13014-014-0277-4. Radiat Oncol. 2014. PMID: 25497602 Free PMC article.
All patients were treated to 35-36.25Gy in 5 fractions delivered with the CyberKnife Radiosurgical System (Accuray). Rectal bleeding was recorded and scored using the CTCAE v.4. Telangiectasias were graded using the Vienna Rectoscopy Score (VRS). ...The media …
All patients were treated to 35-36.25Gy in 5 fractions delivered with the CyberKnife Radiosurgical System (Accuray). Rectal bleeding was rec …
Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis.
Spampinato S, Fokdal LU, Pötter R, Haie-Meder C, Lindegaard JC, Schmid MP, Sturdza A, Jürgenliemk-Schulz IM, Mahantshetty U, Segedin B, Bruheim K, Hoskin P, Rai B, Huang F, Cooper R, van der Steen-Banasik E, Van Limbergen E, Sundset M, Westerveld H, Nout RA, Jensen NBK, Kirisits C, Kirchheiner K, Tanderup K; EMBRACE Collaborative Group. Spampinato S, et al. Radiother Oncol. 2021 May;158:300-308. doi: 10.1016/j.radonc.2020.10.003. Epub 2020 Oct 14. Radiother Oncol. 2021. PMID: 33065183
Risk factors analysis was performed in patients without bladder infiltration and with baseline morbidity available. Cox regression was used for CTCAE grade (G) 3 and G 2 and for EORTC "very much" and "quite a bit" or worse. ...RESULTS: Longitudinal data on 11 …
Risk factors analysis was performed in patients without bladder infiltration and with baseline morbidity available. Cox regression was used …
28 results